Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Kevin M. Bozymski PharmD

Kevin M. Bozymski PharmD profile photo picture

Assistant Professor

Institution: Medical College of Wisconsin
Department: School of Pharmacy Administration
Division: Administration
Program: Administration

Research Experience

  • Antidepressive Agents
  • Antipsychotic Agents
  • Community Mental Health Services
  • Metabolic Syndrome
  • Psychopharmacology
  • Clinical Expertise

  • Evidence-Based Medicine
  • Neurology
  • Psychiatry
  • Educational Expertise

  • Empathy
  • Healthcare Disparities
  • Publications (9)

  • Esketamine: A Novel Option for Treatment-Resistant Depression. (Bozymski KM, Crouse EL, Titus-Lay EN, Ott CA, Nofziger JL, Kirkwood CK) Ann Pharmacother 2020 06;54(6):567-576 PMID: 31795735 SCOPUS ID: 2-s2.0-85077384033 12/05/2019       2 Citations
  • Dysphagia with second-generation antipsychotics: A case report and review of the literature. (Crouse EL, Alastanos JN, Bozymski KM, Toscano RA) Ment Health Clin 2017 Mar;7(2):56-64 PMID: 29955499 PMCID: PMC6007670 06/30/2018    
  • Factors associated with mentor satisfaction among teaching and learning curriculum program participants. (Folz HN, Sprunger TL, Sheehan AH, Aranda J, Bozymski KM, Ramsey DC, Gonzalvo JD) Curr Pharm Teach Learn 2018 04;10(4):427-432 PMID: 29793703 SCOPUS ID: 2-s2.0-85040456555 05/26/2018       2 Citations
  • Caffeine Sodium Benzoate for Electroconvulsive Therapy Augmentation. (Bozymski KM, Potter TG, Venkatachalam V, Pandurangi AK, Crouse EL) J ECT 2018 Dec;34(4):233-239 PMID: 29768288 SCOPUS ID: 2-s2.0-85056573479 05/17/2018       3 Citations
  • The Future of Psychiatry Commission. (Bozymski KM, Ansara ED, Ott CA, Titus-Lay EN, Williams KE) Lancet Psychiatry 2018 01;5(1):15 PMID: 29277201 SCOPUS ID: 2-s2.0-85040132184 12/27/2017    
  • Monitoring and Treating Metabolic Abnormalities in Patients with Early Psychosis Initiated on Antipsychotic Medications. (Bozymski KM, Whitten JA, Blair ME, Overley AM, Ott CA) Community Ment Health J 2018 08;54(6):717-724 PMID: 29127566 SCOPUS ID: 2-s2.0-85033450253 11/12/2017       5 Citations
  • Dolutegravir-induced paresthesias. (Fulco PP, Gomes DC, Bozymski KM) AIDS 2017 Jul 17;31(11):1645-1646 PMID: 28657966 SCOPUS ID: 2-s2.0-85021758981 06/29/2017       1 Citation
  • Development of Collaborative Drug Therapy Management and Clinical Pharmacy Services in an Outpatient Psychiatric Clinic. (Tewksbury A, Bozymski KM, Ruekert L, Lum C, Cunningham E, Covington F) J Pharm Pract 2018 Jun;31(3):272-278 PMID: 28539104 SCOPUS ID: 2-s2.0-85046994125 05/26/2017       1 Citation
  • Pimavanserin: A Novel Antipsychotic for Parkinson's Disease Psychosis. (Bozymski KM, Lowe DK, Pasternak KM, Gatesman TL, Crouse EL) Ann Pharmacother 2017 Jun;51(6):479-487 PMID: 28375643 SCOPUS ID: 2-s2.0-85019020851 04/05/2017       22 Citations
  • Last update: 04/22/2021